Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
147M
-
Number of holders
-
1015
-
Total 13F shares, excl. options
-
187M
-
Shares change
-
-3M
-
Total reported value, excl. options
-
$53.1B
-
Value change
-
-$971M
-
Put/Call ratio
-
0.98
-
Number of buys
-
437
-
Number of sells
-
-496
-
Price
-
$283.58
Significant Holders of BIOGEN INC. - Common Stock (BIIB) as of Q4 2016
1,204 filings reported holding BIIB - BIOGEN INC. - Common Stock as of Q4 2016.
BIOGEN INC. - Common Stock (BIIB) has 1,015 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 187M shares
.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (15.6M shares), VANGUARD GROUP INC (14M shares), STATE STREET CORP (9.36M shares), Clearbridge Investments, LLC (8.77M shares), PRICE T ROWE ASSOCIATES INC /MD/ (8.72M shares), FMR LLC (8.2M shares), BlackRock Institutional Trust Company, N.A. (6.1M shares), WELLINGTON MANAGEMENT GROUP LLP (5.84M shares), BlackRock Fund Advisors (5.3M shares), and Invesco Ltd. (4.25M shares).
This table shows the top 1015 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.